| Product Code: ETC7548834 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neuropathic Pain Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 India Neuropathic Pain Market - Industry Life Cycle |
3.4 India Neuropathic Pain Market - Porter's Five Forces |
3.5 India Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 India Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 India Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 India Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 India Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 India Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 India Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases leading to neuropathic pain |
4.2.2 Growing elderly population in India |
4.2.3 Rising awareness about neuropathic pain and its treatment options |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas |
4.3.2 High cost of neuropathic pain medications and treatments |
4.3.3 Lack of trained healthcare professionals specializing in neuropathic pain management |
5 India Neuropathic Pain Market Trends |
6 India Neuropathic Pain Market, By Types |
6.1 India Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 India Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 India Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 India Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 India Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 India Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 India Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 India Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 India Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 India Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 India Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 India Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 India Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 India Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 India Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 India Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 India Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 India Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 India Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 India Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 India Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 India Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 India Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 India Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 India Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 India Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 India Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 India Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 India Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 India Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 India Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 India Neuropathic Pain Market Import-Export Trade Statistics |
7.1 India Neuropathic Pain Market Export to Major Countries |
7.2 India Neuropathic Pain Market Imports from Major Countries |
8 India Neuropathic Pain Market Key Performance Indicators |
8.1 Number of new clinical trials for neuropathic pain treatments conducted in India |
8.2 Percentage increase in public awareness campaigns about neuropathic pain |
8.3 Adoption rate of alternative pain management therapies in India |
9 India Neuropathic Pain Market - Opportunity Assessment |
9.1 India Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 India Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 India Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 India Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 India Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 India Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 India Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Neuropathic Pain Market - Competitive Landscape |
10.1 India Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 India Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here